Learn more about our latest achievements, product updates, and our involvement in research projects
Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study
Monsenso is participating in R-LiNK, the major new study for developing a more complete understanding of the reactions and effects of taking lithium. Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.
Monsenso is proud to be a consortium partner in the international team consisting of SME companies, universities, and research centres for the Horizon 2020 funded WellCo project. Our mHealth solution will lead the mental health component of this new ICT solution, designed to help users improve their physical, mental & cognitive well-being.
Copenhagen, Denmark – 19 December 2017 Monsenso, a Danish developer in mobile health solutions for mental health has partnered with On the Line, an Australian social health business. On the Line offers telephone, web chat and video counselling and social media moderation services 24/7 to more than 80,200 people each year.
The Mental Health Services in the Region of Southern Denmark are currently rolling out the Monsenso mHealth solution to support the treatment of individuals with affective disorders, including anxiety, bipolar, schizophrenia and borderline personality disorder.
Copenhagen, Denmark – 28 August 2017. Monsenso, a technology leader in mobile health (mHealth) solutions for mental health, has been granted the ISO 27001 certification. This is the international standard that describes best practices for an information security management system (ISMS).
Copenhagen, Denmark – 18 July 2017 Monsenso, a Danish developer in mobile health solutions for mental health, has announced that Datlinien, a private clinic in Denmark, will soon implement the Monsenso mHealth solution with an added Dialectical Behavioural Therapy (DBT) module.
Copenhagen, Denmark – 28 June 2017. The IMPACHS project funded by Eureka/Eurostars and the Innovation Fund in Demark, has the aim to design, develop and provide clinical evidence for the use of smartphone-based intervention technology for outpatients diagnosed with schizophrenia, to improve the availability and cost-effectiveness of mental healthcare.
Copenhagen, Denmark 24 April 2017 – Monsenso is a finalist for Best eHealth solutions in Europe. The Danish technology company developing mHealth solutions for mental health, was shortlisted for the Champions category.
Copenhagen, Denmark – 7 April 2017. Monsenso, a Copenhagen-based technology company developing mHealth solutions for mental health, today announced a partnership with Gen Re, one of the world’s leading reinsurance companies. The objective of the partnership is to help insurance companies take advantage of Monsenso’s mHealth solution, which can assist in the prevention, early intervention and treatment of mental illness.
Copenhagen, Denmark – 31 January 2017. Monsenso, Region Zealand, and two German partners have been granted major funding by Eureka/Eurostars, for the “IMProving Availability and Cost-effectiveness of mental Healthcare for Schizophrenia through mHealth” (IMPACHS) project. The objective of IMPACHS is to design and develop a mobile- and context-aware Cognitive Behaviour Therapy (CBT) content integrated into Monsenso Clinic.